Related Experiment Video
Updated: Aug 19, 2025

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
IND-2, a Quinoline Derivative, Inhibits the Proliferation of Prostate Cancer Cells by Inducing Oxidative Stress,
Swapnaa Balaji1, Rabin Neupane1, Saloni Malla1
1Department of Pharmacology and Experimental Therapeutics, College of Pharmacy & Pharmaceutical Sciences, University of Toledo, Toledo, OH 43614, USA.
Abstract:
In men, prostate cancer (PC) is the most frequently diagnosed cancer, causing an estimated 375,000 deaths globally. Currently, existing therapies for the treatment of PC, notably metastatic cases, have limited efficacy due to drug resistance and problematic adverse effects. Therefore, it is imperative to discover and develop novel drugs for treating PC that are efficacious and do not produce intolerable adverse or toxic effects. Condensed quinolines are naturally occurring anticancer compounds. In this study, we determined the in vitro efficacy of IND-2 (4-chloro-2-methylpyrimido[1″,2″:1,5]pyrazolo[3,4-b]quinolone) in the PC lines, PC-3 and DU-145. IND-2 significantly inhibited the proliferation of PC-3 and DU-145, with IC50 values of 3 µM and 3.5 µM, respectively. The incubation of PC-3 cells with 5 and 10 µM of IND-2 caused the loss of the mitochondrial membrane potential in PC-3 cells. Furthermore, IND-2, at 5 µM, increased the expression of cleaved caspase-3, cleaved caspase-7 and cleaved poly (ADP-ribose) polymerase (PARP). The incubation of PC-3 cells with 5 µM of IND-2 significantly decreased the expression of the apoptotic protein, B-cell lymphoma 2 (Bcl-2). Furthermore, 5 and 10 µM of IND-2 produced morphological changes in PC-3 cells characteristic of apoptosis. Interestingly, IND-2 (2.5, 5 and 10 µM) also induced mitotic catastrophe in PC-3 cells, characterized by the accumulation of multinuclei. The incubation of DU-145 cells with 1.25 and 5 μM of IND-2 significantly increased the levels of reactive oxygen species (ROS). Finally, IND-2, at 10 μM, inhibited the catalytic activity of topoisomerase IIα. Overall, our findings suggest that IND-2 could be a potential lead compound for the development of more efficacious compounds for the treatment of PC.
Insights
IND-2, a novel compound, effectively inhibits prostate cancer (PC) cell growth and induces apoptosis. This research highlights IND-2 as a promising candidate for developing new PC treatments with fewer side effects.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Prostate cancer (PC) is a leading cause of cancer-related deaths in men, with current treatments facing challenges like drug resistance and adverse effects.
- Novel therapeutic agents are urgently needed for effective PC treatment, especially for metastatic cases.
- Condensed quinolines represent a class of natural compounds with known anticancer properties.
Purpose of the Study:
- To evaluate the in vitro anticancer efficacy of IND-2, a novel condensed quinoline derivative, against human prostate cancer cell lines (PC-3 and DU-145).
- To elucidate the mechanisms underlying IND-2's anti-proliferative effects, including its impact on apoptosis, mitochondrial function, and cell cycle progression.
Main Methods:
- In vitro assays were performed on PC-3 and DU-145 prostate cancer cell lines.
- Cell proliferation was assessed using IC50 values.
- Apoptosis was evaluated by measuring mitochondrial membrane potential, caspase activation, Bcl-2 expression, and observing morphological changes.
- Mitotic catastrophe, reactive oxygen species (ROS) levels, and topoisomerase IIα activity were also analyzed.
Main Results:
- IND-2 demonstrated significant inhibition of PC-3 and DU-145 cell proliferation with IC50 values of 3 µM and 3.5 µM, respectively.
- IND-2 induced apoptosis in PC-3 cells by decreasing mitochondrial membrane potential, increasing cleaved caspase-3, -7, and PARP, and reducing Bcl-2 expression.
- IND-2 triggered mitotic catastrophe in PC-3 cells, elevated ROS levels in DU-145 cells, and inhibited topoisomerase IIα activity.
Conclusions:
- IND-2 exhibits potent in vitro anticancer activity against prostate cancer cell lines through multiple mechanisms, including apoptosis induction and mitotic catastrophe.
- The findings suggest that IND-2 has the potential to be a lead compound for developing novel and more efficacious prostate cancer therapeutics.
- Further research into IND-2 could pave the way for new treatment strategies targeting drug-resistant and metastatic prostate cancer.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Inhibition of Cdk Activity
Abnormal Proliferation
Negative Regulator Molecules
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...

